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Introduction: In the event of chronic diabetes or burn wounds, accomplishing skin regeneration is a major
concern. Autologous skin grafting is the most effective remedy, but the tissue harvest may create more nonhealing
wounds. Currently available skin substitutes have a limited clinical outcome because of immune reactions arising
from the xenobiotic scaffold or allogenous cells. Autologous stem cells that can be collected without an additional
injury may be a viable option for skin-tissue engineering. Presence of a low number of keratinocyte progenitor cells
(KPCs) within the peripheral blood mononuclear cell (PBMNC) population has been indicated. Identification,
isolation, expansion, and differentiation of KPCs is necessary before they are considered for skin regeneration, which
is the focus of this study.
Methods: Culture of isolated human PBMNCs on a cell-specific matrix was carried out to induce differentiation of
KPCs. Flow cytometry and reverse transcriptase polymerase chain reaction were done for epithelial stem cell marker
p63 and lineage markers cytokeratin 5 and cytokeratin 14, to track differentiation. Proliferation was confirmed by
quantifying the proliferating cell nuclear antigen-expressing cells. Immunostaining with epithelial cell markers,
involucrin and filaggrin, was carried out to establish terminal differentiation. Microscopic analysis confirmed growth
and survival of KPCs on the dermal fibroblast monolayer and on a transplantable fibrin sheet.
Results: We demonstrated that KPCs are p63+ and CD34-. The specifically designed composition of the extracellular
matrix was found to support selective adhesion, proliferation, and differentiation of p63+ KPCs. The PBMNC culture
for 12 days under controlled conditions resulted in a homogenous population that expressed cytokeratins, and
>90% of the cells were found to proliferate. Subculture for 5 days resulted in expression of filaggrin and involucrin,
suggesting terminal differentiation. Transfer of matrix-selected KPCs to a dermal fibroblast monolayer or fibrin
supported cell proliferation and showed typical hexagonal morphology of keratinocytes within 15 days.
Conclusions: Circulating KPCs were identified with p63, which differentiated into keratinocytes with expression of
the cytokeratins, involucrin and filaggrin. Components of the specifically designed matrix favored KPC attachment,
directed differentiation, and may turn out to be a potential vehicle for cell transplantation.
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For the cure of chronic ulcers, tissue-engineered skin sub-
stitute has been proven to produce a positive outcome.
However, because the commercially available skin substi-
tutes use xenobiotic scaffold material or allogenic cells [1],
the outcome is limited. Therefore, identification of a suit-
able cell source and a biocompatible culture matrix is crit-
ical for successful skin-tissue engineering.
The major requirements of the cells to be used for skin-
tissue engineering are that they should not be terminally
differentiated, they must possess proliferation potential,
and they must be lineage committed. It has been shown
that the bone marrow-derived stem cells (BMDSCs) could
differentiate into a number of different cell types, includ-
ing epidermis [2]. In many instances, BMDSCs leave bone
marrow, circulate in the blood, and are found in peripheral
blood mononuclear cell (PBMNC) fractions [3]. A subset
of PBMNCs is considered to be multipotent and to ac-
quire macrophagic, epithelial, endothelial, neuronal, and
hepatocytic phenotypes [4]. The bone marrow-derived
mesenchymal stem cells (MSCs) have been shown to dif-
ferentiate into keratinocyte-like cells in vitro [5]. Sasaki
et al. [6] showed that MSCs are recruited into wounded
skin and contribute to wound repair by differentiation into
skin cells. Medina et al. [7] reported that circulating bone
marrow-derived CD34+ cells may have the capacity to
transdifferentiate into epithelium-like cells. They also
showed recently that CD14+ monocytes could differentiate
into keratinocyte-like epithelial cells [8]. All these results
suggests that, other than the basal stem cells that are re-
sponsible for normal epithelial homeostasis, circulating
progenitors may also contribute to epithelial layer regener-
ation. However, none of these studies used a specific
marker for demonstrating the presence of keratinocyte
lineage-committed stem cells in peripheral blood, which
could be directed to skin epithelium.
A homologue of p53, p63, is an essential transcription
factor for epithelial development and proliferation. This
molecule was shown to distinguish keratinocyte stem cells
from their transiently amplifying (TA) progenitors involved
in skin generation [9]. It was also shown that TA cell cul-
tures express a cell proliferation-associated nuclear antigen
(PCNA). Therefore, the presence of p63 indicates that the
cells can proliferate, form clones, and maintain stemness.
The transcription factor p63 is also required for epidermal
lineage commitment, epidermal differentiation, cell adhe-
sion, and basement membrane formation [10]. Once the
basal stem cells reach the suprabasal region, p63 may be
downregulated; subsequently proliferation may be arrested.
Therefore, it is a probable candidate to be present on
lineage-committed keratinocyte progenitor cells (KPCs) as
well. Because KPCs are present in low numbers in circula-
tion, it is essential for them to have good proliferation po-
tential if they are to be involved in epithelial regeneration.In addition to p63, the stem cells in the basal layer also
contain keratin bundles such as cytokeratin 5 (CK5) and
cytokeratin 14 (CK14), and once they differentiate, add-
itional molecules such as filaggrin and involucrin are
expressed.
Attachment and multiplication of the identified stem or
progenitor cell in vitro and in vivo require an appropriate
substrate that has adhesion sites and signaling molecules.
In physiology, p63+ stem cell proliferation takes place on
the basement membrane, which consists of fibronectin,
laminin, collagen, and growth factors. Fibrin clot is the nat-
ural scaffold that promotes wound healing in almost all re-
gions of the human body and more specifically in skin
repair. A naturally formed fibrin clot at the injury site con-
tains important adhesive proteins, such as fibronectin, and
growth factors released from platelets and from other cells
such as fibroblasts. Exogenous fibrin matrix, carefully com-
posed of cell-specific growth factors, is proven to be suit-
able for differentiation of endothelial progenitor cell [11]
and neural progenitors [12]. Therefore, a fibrin-based, cell-
specific matrix composition may be designed to support
attachment and differentiation of KPCs. The extracellular
matrix (ECM) molecules, which are important for growth
of skin cells, are epidermal growth factor (EGF), angiogenic
growth factors (AGFs), hyaluronic acid (HA), gelatin, lam-
inin, and fibronectin.
In this study, p63, cytokeratins (CK5 and CK14), in-
volucrin, and filaggrin antigens were used as markers to
establish the lineage of KPCs and their differentiation after
culture on the specifically designed matrix. The results
may lead to a novel approach for treating chronic wounds
with a tissue-engineered skin substitute derived from au-
tologous keratinocyte progenitors isolated from blood and
grown on a human plasma-derived fibrin matrix.
Methods
Gelatin, formaldehyde, Histopaque 1077, ascorbic acid,
heparin, insulin, 40,6-diamidino-2-phenylindole (DAPI),
hydrocortisone, agarose, and TritonX-100 were from Sigma
Aldrich (St. Louis, MO, USA). DMEM: F12 medium,
trypsin-EDTA, and antibiotic-antimycotic were from
GIBCO BRL (Now part of Invitrogen Corporation, Grand
Island NY, USA). Epidermal growth factor (EGF) was from
R &D Systems (Minneapolis, MN, USA), and polystyrene
culture dishes were from Nunc (Roskilder, Denmark). In-
house prepared materials used were bovine hypothalamus
extract (BHE) prepared from young calf tissue, according to
the method of Maciag et al. [13], hyaluronic acid (HA) pre-
pared from human umbilical cord [14] and dialyzed new-
born calf serum, cryoprecipitated fibrinogen concentrate
from human plasma, and purified human thrombin [15].
The complete medium contained 10% newborn calf serum,
5 μg/ml insulin, 0.3 mM ascorbic acid, 25 μg/ml BHE, 0.5
μg/ml hydrocortisone, and 20 ng/ml EGF, and 10 μl/ml
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Castra, Newcastle upon Tyne, UK), phycoerythrin (PE) con-
jugated anti-human cytokeratin5 (Santa Cruz Biotechnology,
Santa Cruz, CA, USA), anti-human cytokeratin14 (Nova
Castra), FITC-conjugated antihuman proliferating cell nu-
clear antigen (PCNA) (Caltag, now part of Invitrogen Cor-
poration, Grand Island NY, USA), antihuman involucrin
(Nova Castra), and antihuman filaggrin (Santa Cruz Biotech-
nology) were used as markers for various experiments.
Secondary antibodies used were FITC- or PE-conjugated
anti-mouse IgG from Santa Cruz Biotechnology or Abcam
(Cambridge Science Park, Cambridge, UK).
Matrix preparation
Culture plates were coated with fibrin composite, accor-
ding to the established procedure of Chennazhy and
Krishnan [15], with a modified fibrinogen cocktail (FC).
The modified FC consists of fibrinogen (2 mg/ml), fi-
bronectin (200 μg/ml), gelatin (0.2%), BHE (25 μg/ml),
EGF (20 ng/ml), and HA (0.1 mg/ml). The fibrin net-
work in the culture dish were lyophilized and stored at
4°C until use. A fibrin sheet was prepared, as described
earlier [16]. In brief, 1.0 ml of fibrin composite, as de-
scribed earlier, was mixed with 1.0 ml (5 IU) thrombin
to make a clot in a culture well (about 3.3 cm diameter)
and was lyophilized to form a stable sheet. The fibrin
sheet was suspended in the medium for 5 to 10 minutes
before using for cell culture.
Isolation of peripheral blood mononuclear cells
Isolation of PBMNCs from the buffy coat (discards from
Blood Bank collected with informed consent) was done
with Histopaque-1077 density gradient centrifugation. As
per the standard operating procedure of Institutional Eth-
ics Committee, Sree Chitra Tirunal Institute for Medical
Sciences and Technology (IEC-SCTIMST), the collection
of discarded buffy coat is exempted from review if the
donor identity is not publicized. In brief, red blood cells
(RBCs) were settled by centrifugation of the buffy coat at
1,200 g for 15 minutes in 15-ml centrifuge tubes (Hareus
Stratos, Hanau, Germany). Superficial plasma was
discarded; PBMNCs at the interface were collected and di-
luted with equal volumes of Hank Balanced Salt Solution
(HBSS), layered over Histopaque-1077 in centrifuge tubes
(Nunc, Roskilder, Denmark), and centrifuged at 400 g for
30 minutes at 25°C. The layer containing PBMNCs was
carefully separated from the plasma-Histopaque interface
and was washed with serum-free DMEM: F12 by centrifu-
gation at 150 g at 4°C for 10 minutes. The washed
PBMNCs were suspended in complete medium.
Cell culture
The PBMNCs suspended in complete medium were ini-
tially seeded in bare 20-cm2 culture dishes and wereincubated for 1 hour in a humidified incubator under 5%
CO2 at 37°C. After 1 hour, the medium was removed gen-
tly, and fresh medium was added. After 48 hours, the
medium was removed, and nonadherent but settled cells
were flushed with complete keratinocyte culture medium,
and the cells attached to the bare polystyrene surface were
discarded. The plastic-nonadherent cells were seeded onto
matrix-coated dishes and were incubated in a humidified
incubator under 5% CO2 at 37°C. The medium was re-
placed with fresh medium each day until 72 hours; after-
ward, the medium was changed on alternate days. The
morphology of cultured cells was observed with a phase-
contrast microscope (Leica Microsystems, DMIRB Wetzlar,
Germany).
Fibroblasts were isolated from human foreskin from a
local hospital (collected with informed consent) by using a
standard protocol [17]. Cells were subcultured, and either
the third- or the fourth-passage monolayer was used for
seeding KPCs. The protocol for co-culture was to seed
PBMNCs in an uncoated dish for 48 hours, transfer to a
coated dish, and after 4 days on biomimetic matrix, KPCs
were flushed out and seeded onto either a fibroblast
monolayer or a fibrin sheet. Culture was continued in the
same medium composition as described earlier.
Immunostaining for fluorescence microscopy
Cells cultured on FC-coated 1.75-cm2 wells for a specific
period of time were rinsed with phosphate-buffered saline
(PBS), fixed with 3.7% formaldehyde in PBS, washed with
PBS, and permeated with Triton X-100 (0.1%) in PBS. Cells
were then incubated with primary antibodies against p63
(1:50), FITC-conjugated cytokeratin 14 antibody (1:50), or
with phycoerythrin (PE)-conjugated cytokeratin 5 (1:50),
antiinvolucrin (1:100), and antifilaggrin (1:100). Conjugated
secondary antibody was used at 1:200 dilution, and cul-
tures were viewed by using a fluorescence microscope
(Leica Microsystems, DMIRB, Wetzlar, Germany). Actin
staining was done by using phalloidin conjugated with
Texas Red (Molecular Probes, now part of Invitrogen Cor-
poration, Grand Island NY, USA), and for nuclear staining
of cells, DAPI (Sigma Aldrich) was used.
Flow cytometry
Cells in culture for 1 hour, 4 days, 8 days, and 12 days
were harvested by flushing out or by using the standard
trypsinization protocol (0.25% Trypsin-EDTA for 3 mi-
nutes), washed with PBS, fixed with 3.7% formaldehyde in
PBS for 20 minutes, washed with PBS, and permeated
with Triton X-100 (0.1%) in PBS for 5 minutes. The cells
were treated with 1% bovine serum albumin (Sigma-Al-
drich, St. Louis, MO, USA) in PBS for 30 minutes and in-
cubated with FITC-conjugated antibodies against PCNA
(1:100), CK14 (1:200), phycoerythrin-conjugated CK5
(1:100), and nonconjugated p63 (1:100) antibody for 2
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were washed and treated with FITC-conjugated secondary
antibody (1:200) for 1 hour. After the staining procedure,
the cells were washed and analyzed by using a flow
cytometer (FACS ARIA, BD Biosciences, San Jose, CA,
USA). The percentage of marker-expressed cells was cal-
culated by using BD FACS Diva software (BD Biosciences,
San Jose, CA, USA).
Sorting of CD34+ cells from the PBMNCs was done
from the enriched Histopaque gradient centrifugation
step, seeded on bare polystyrene for at least 1 hour, and
the cells harvested from bare polystyrene were stained
with CD34 antibodies conjugated with APC (BD Biosci-
ences, Franklin Lakes, NJ, USA) and sorted by using
FACS Aria (BD Biosciences). A portion of the sorted
cells was used for analysis of purity, and the remaining
cells were fixed, permeated, and stained with p63, as de-
scribed earlier, and analyzed.
Reverse transcriptase-polymerase chain reaction
For detecting expression of markers before and after cul-
ture, RT-PCR analysis was performed. Total RNA was
extracted from the cells in culture on day 1 and day 12
by using Trizol reagent (Invitrogen Invitrogen Corpor-
ation, Grand Island NY, USA) according to manufac-
turer’s protocol. RNA, 1 μg, was converted to cDNA by
using superscript III reverse transcriptase enzyme
(Invitrogen Corporation). The expression of keratinocyte
lineage markers, such as TAp63, ΔNp63, CK5, and CK14,
was analyzed with RT-PCR. For amplification reactions,
Master cycler from Eppendorff (Hamburg, Germany) was
used for 40 cycles; the annealing temperature for all reac-
tions was 54°C, and the product was analyzed for molecu-
lar size by using agarose gel electrophoresis. GAPDH was
used as a positive control. The primer sequence used for
each gene is given in Table 1. For each gene, an assess-
ment of quality was performed by examining PCR melt
curves after real-time PCR by using a Chromo4 system
(MJ Research, now part of Bio-Rad, Hercules, CA, USA)
to ensure specificity.
Results
In the preliminary experiments, different compositions of
matrices were found to support adhesion of KPCs from






CK14 50-gaccattgaggacctgagga-30survival, multiplication, lineage commitment, and differen-
tiation, several modifications were necessary. The final
composition of fibrinogen composite (FC) described earlier
was found to be suitable for attaining cell survival and
multiplication. The cells were initially seeded on bare poly-
styrene culture wells, and the floating cells were removed at
least 3 times within a period of 48 hours of starting the cul-
ture. The process involved light swirling of the culture
plates and aspiration of medium, which was replaced with
fresh medium to eliminate many of the nonspecific cells
from the culture. The unattached cells that had settled at
the bottom were likely to have many multipotent adult pro-
genitor cells (MAPCs), so they were flushed out and seeded
onto the FC-coated dishes. Within 1 hour of seeding on
FC, the floating cells were removed. The attached cells were
found to form small groups of four to six cells and were
uniformly distributed in the culture well (Figure 1A). When
the medium was changed on alternate days, more floating
cells were removed. Cells were analyzed periodically, and
on days 4, 8, and 12, many fields were viewed to check the
frequency of cell colonies and morphologic variations, if
any, and were micrographed. The size of the colony was
found to increase with time (Figure 1B through D). In most
of the experiments, the cells grew around the initial colony
and filled the culture well in 12 days (Figure 1D). A con-
tinuous bed of cells was seen in 15 days (Figure 1E, F).
Until the fourth day, cells were not tightly adhered to the
culture substrate and could be harvested by flushing with
medium, for transfer to other substrates or for analysis. At
later periods, cells were attached tightly to the matrix and
could be harvested only by the standard trypsinization
method.
For identification of KPCs among the cells seeded onto
the FC, p63, CK5, and CK14 were analyzed by using
flow cytometry. Compiled data of flow-cytometric ana-
lysis of cells harvested on days 1, 4, 8, and 12 is shown
in Figure 2A. The sample that was analyzed on day 1
was obtained after 1 hour of PBMNC culture on an un-
coated dish. On all days, excluding the debris, all cells
from the FSC-versus-SSC plot were gated; and in the
SSC-versus-FL1/FL2 plot, the gate having <0.5% was se-
lected for detection of the positively stained population.
Among the cells obtained after 1 hour, few were p63+ in
the gated region. The p63+ cells were prominent in the
monocyte region of the FSC-versus-SSC plot. No CK14+sis
Reverse primer Amplicon size





Figure 1 Representative phase-contrast micrographs of cells on fibrinogen composite (FC) matrix. (A) Cells on the day of seeding; (B) on
day 4 of seeding; (C) on day 8; (D) on day 12; (E, F), on day 15. A through E are at low magnification (scale bar, 200 μm), and F is at higher
magnification (scale bar, 50 μm).
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Tracking of progenitor /differentiation markers from
days 1 to 12 was made possible by using culture of
single-donor PBMNCs in at least four culture wells of
10 cm2 area, and cells from each well were aspirated for
measurement on each specified day (one dish per
period). From day 8 onward, almost all cells in the FSC-
versus-SSC plots were in a single cluster, which indi-
cated that the cells were homogeneous as compared
with previous periods in terms of size and granularity.
By day 12, about 90% of cells were positive for both p63
and CK14, but the percentage of CK5 was lowest among
the three antigens. Of the cells that survived on day 4,
69% ± 8% were p63+, 4% ± 2.5% were CK5+, and 4.9% ±
3% were CK14+. This finding suggests that all p63+ cells
may have survived, and some of them seemed to have
differentiated into keratinocyte lineage with CK5 and
CK14 expression by day 4. Obviously, specific KPC ad-
hesion to the FC occurred, and floating cells were elimi-
nated from the culture over a period of 4 days. The
higher percentage of p63+ cells on day 4 as compared
with day 1 may be due to the elimination of largenumber of nonspecific cells from the culture and prolifera-
tion of p63+ KPCs. A remarkable difference was seen in
CK5 and CK14 expression on cells cultured for 8 days.
Whereas p63+ cells were about 80% of the total viable
population, >95% were CK5+, and >80% were CK14+.
Average ± standard deviation (SD) of the values from three
donors (Figure 2A) show similar progression of expression
for p63, CK5, and CK14, with the lowest SD by day 12 of
culture. A differentiation experiment was done by using
PBMNCs from many other donors for confirming differen-
tiation; however, tracking and quantification of marker ex-
pression by using three donors only is presented here.
Overall, it was observed that if the PBMNC yield was good,
the cell survival and expression of markers was also as
good, as the data show in Figure 2. But if PBMNC yield
and seeding density were poor, cell survival and marker ex-
pression were poor, too. It appeared that seeding density is
crucial for KPC survival, with the best results when the
seeding density of leukocytes was about 1 × 106/cm2 of the
biomimetic matrix.
In Figure 2B, results of the gene-expression analysis are
shown. In cells on day 1, one isoform of p63 (TAp63) was
Figure 2 Evidence for differentiation. (A) Compiled data of
flow-cytometric analysis during cell culture. The percentage of cells
positive for p63, CK5, and CK14 on each day of analysis during the
periods of culture is presented. Periods of analysis against the
percentage of positive cells for each parameter are marked in the
respective axis. Average ± SD of replicate experiments (n = 3),
carried out by using different donor PBMNCs are presented. The
values are plotted in the bar diagram for comparison of percentage
of positive cells on each day. CK14- and CK5-positive cells were
absent on day 1. (B) Expressions of p63, CK5, and CK14 genes on the
day of starting the culture and after 12 days of culture. GAPDH was
the housekeeping gene, and TAp63 was the only KPC-specific gene
that amplified on day 1. ΔNp63, CK5, and CK14 were expressed on
day 12, and the products showed specific molecular size.
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fied in 40 cycles of reaction. In cells on day 12, TAp63,
ΔNp63, CK5, and CK14 genes were clearly expressed.
These data confirm that p63, CK5, and CK14 are expressed
when PBMNCs were cultured on the KPC-specific niche in
this study. How cells were stimulated to the keratinocyte
lineage during the later period of cell culture is beyond the
scope of this study. It is likely that the molecules present on
the culture matrix and in the medium together would have
influenced the keratinocyte lineage commitment and ex-
pression of more keratinocyte markers.
The KPCs were found to proliferate during the culture
period, and big clusters were found frequently throughoutthe culture surface. The proliferation marker used was
PCNA, and an average of 60% of the gated cells were
PCNA positive on day 1; gradually the average reached
>95% by day 8, but by day 12, the percentage of proliferat-
ing cells decreased to 80% (Figure 3). The reason for the
lower percentage of proliferating cells on the initial day
may be that the cells were more heterogeneous at that time,
and other nonspecific and nondividing cells contaminated
the gated region; large donor-to-donor variability was seen
during this period. Once they became more homogeneous
on day 8 with >95% of cells expressing CK5 (Figure 2A),
they were all expressing PCNA as well (Figure 3). The pro-
liferation potential was reduced by day 12, may be because
terminal differentiation progressed.
The surface marker CD34 has been reported to be posi-
tive on many MAPCs in circulation. To test for its pres-
ence on p63+ KPCs, CD34+ cells were sorted by using
FACS Aria. Purity of the sorted cell population was >70%.
When the sorted cells were permeated and stained with
p63 antibodies, none of the CD34+ cells was found to be
p63+ (Figure 4A through F). Even though KPCs are likely
to be of bone-marrow origin, once committed to the
lineage and expressed p63, they do not seem to be CD34+.
The data were consistent in three sorting experiments,
which were done by using three different donor PBMNCs.
In this study, we found that p63 is a useful marker to
identify keratinocyte progenitors in the circulating blood,
which could survive in the culture. With a nuclear anti-
gen, permeation of cells is necessary to stain p63, so it
cannot be used as a marker to sort KPCs from PBMNC
fractions. Because the cells are CD34-, it too cannot be
used to sort KPCs from PBMNCs; therefore, matrix-
directed cell attachment, proliferation, and differenti-
ation are the most suitable strategies to culture-amplify
numbers of KPCs for use in regenerative medicine.
To confirm keratinocyte lineage commitment and differ-
entiation, cultures were fixed and stained with five
markers, which included p63, CK5, CK14, filaggrin, and
involucrin. Fibroblasts from human foreskin were used as
negative control for all antigens (not shown). Most of the
cells in the clusters formed by day 4 of culture (Figure 5A,
B) stained positive for p63 (Figure 5C); from the magnified
micrograph (Figure 5D, D1), antigen seems to be located in
the nucleus. These data correlated well with the flow-
cytometry data obtained on day 4 (Figure 2A), which sug-
gests that about 70% of the cells in culture dishes are p63+.
Some of the cells in the periphery were also p63+, but
could not be focused together with the cluster when im-
ages were taken.
For CK5, CK14, filaggrin, and involucrin immunostain-
ing, the cells in first-passage culture were used, and
stained cells are shown in Figure 6. After subculture, the
KPCs were able to survive when they were seeded onto a
fresh matrix-coated dish. Both antigens CK14 (Figure 6A)
Figure 3 Data on flow-cytometric analysis of proliferation marker in cells during the period of culture. PCNA analysis of the cells was
done after staining the cells with FITC-conjugated antibodies. (A) Representative histogram of unstained control. (B through E) histograms of
PCNA-stained cells on day 1, day 4, day 8, and day 12, respectively, and (F) graphic representation of compiled data. Percentage of PCNA-positive
cells from three replicate experiments is compiled, and the average ± SD of data from experiments carried out by using different donors’
PBMNCs is presented as a bar graph to compare percentage of PCNA-positive cells between the days of analysis. Days of analysis are marked on
the x-axis, and percentage of positive cells on the y-axis of the bar diagram.
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cells, leaving the nuclear region distinctly negative; thus,
the flow-cytometry data were substantiated by immuno-
fluorescent micrographs. Merged images of CK14 and
CK5 shown in Figure 6C illustrate colocalization of the
cytokeratins. The cells expressed involucrin, which
appeared as a distinct granule in the cell cytoplasm
(Figure 6D). They also showed expression of filaggrin,
which appeared as a string of granules in cytoplasm
(Figure 6E). The cells did not express involucrin and
filaggrin unless they were allowed to grow for 5 days in
subculture. Passaging to a fresh matrix was done after 12
days of culture on the initial differentiation matrix.
When matrix-selected cells were transferred to the
fibroblast monolayer on day 4 of culture, attached cellswere distributed throughout the culture area (Figure 7-
A). After 7 days of growth on the fibroblast surface,
clones of KPC could be seen (Figure 7B). By day 17, cells
were found to have covered the fibroblast layer, except
in some area (Figure 7C). The cells showed the typical
hexagonal morphology of keratinocytes on staining
them with actin (Figure 7D). A fibrin sheet, which can
be used as a biomimetic scaffold to transplant KPC, is
shown in Figure 8; a lyophilized sheet is shown in
Figure 8A. The scaffold is stable and can be lifted with
forceps for implantation, as shown earlier [14], and KPC
isolated in vitro can be transplanted onto the sheet. To
demonstrate that the cells attach and survive on a fibrin
sheet after 4 days in the culture dish, cells were flushed
out and were transferred to the fibrin sheet suspended in
Figure 4 Data on flow-cytometric analysis of sorted CD34+ cells for the presence of p63. For analysis of CD34, primary antibodies
conjugated with APC (FL1), and for bound p63 antibody, secondary antibodies conjugated with FITC (FL2) were used. (A) Representative
FSC-versus-SSC plot of unstained PBMNCs flushed from uncoated PS plates. (B) Plot of FL1 versus SSC of unstained PBMNCs. (C) Representative
plot of FL1-CD34-stained PBMNCs before sorting. (D) Representative plot of FL1-CD34 sorted cells. (E) Representative plot of FL2-versus-SSC
sorted cells. (F) Representative plot of SSC-versus-FL2-p63 stained cells.
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scaffold appeared as a thin membrane-like structure that
could be lifted (Figure 8C). Handling of the sheet after cul-
ture was difficult for imunostaining; so simple DAPI stain-
ing was done to demonstrate that the cells transferred
from the biomimetric matrix-coated culture dish survived
on the fibrin sheet as well. Because of the three-
dimensional and porous structure of the sheet, the cells
penetrated into the matrix and DAPI-stained nucleus
(Figure 8D) and were seen in different planes under the
fluorescence microscope. The flow-cytometric analysis hadproven that by day 4, >70% of the cells in the fibrin-coated
culture dish were p63+ (Figure 2A), so the DAPI-stained
cells are expected to be p63+ KPCs.
Thus when PBMNCs were cultured under the speci-
fied conditions on the fibrin matrix, which comprised
growth factors, adhesive proteins, and hyaluronic acid, a
homogeneous population of KPCs was obtained. The re-
sults are promising because KPCs differentiate on the
matrix and can be transplanted by using a dermal equiva-
lent such as a fibrin sheet or a fibroblast sheet to support
KPC survival and differentiation.
Figure 5 Identification of p63-specific cells in clusters. (A) Light micrograph of a representative cluster on day 4. (B) DAPI-stained cell cluster.
(C) Immunostained p63-positive cells in the cluster. (D) Magnified micrograph of p63+ cells. (A through C) The same cluster is imaged with
different filter settings (scale bar, 100 μm). (D) Scale bar, 50 μm; D1 40×.
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Application of stem cells in skin grafting and tissue engin-
eering is an important area of research in regenerative
medicine. An important step in the use of stem cells for tis-
sue engineering is to obtain a relatively pure population
that retains multiplication potential. The primary objective
of this study was to find an easy-to-access autologous adult
stem cell or progenitor cells for skin-tissue engineering.
Further, a well-defined and efficient protocol must be devel-
oped for directing the commitment and differentiation of
stem cells into the keratinocyte lineage for epidermal regen-
eration. The development of such protocols would reduce
the likelihood of spontaneous differentiation of multipotent
stem cells into undesired lineages on transplantation.
In this study, we identified p63+ KPCs in the circulation
by using flow cytometry, but the origin is not clear. They
may have reached circulation either from the bone mar-
row or from the epidermal compartment. Once commit-
ted to the specific lineage that expresses p63, they do not
seem to be CD34+. Use of p63 as a marker for identifica-
tion of circulating KPCs is a novel approach that we used
in this study. To the best of our understanding, this is the
first report on the presence of p63+ cells in blood. We
used a matrix-directed signaling strategy to amplify the
number of progenitors and thus generated a homogeneous
lineage committed culture that co-expressed p63, CK5,
and CK14.
The presence of transit-amplifying cells at the injured tis-
sue has been reported, and they probably originated from
bone marrow and differentiated into keratinocytes [18].They showed that the extent of skin damage influences the
engraftment of bone marrow-derived progenitors, and the
process continues until 3 weeks after the injury. Korbling
and colleagues [19] found that on transplanting peripheral
blood stem cells, they differentiated into mature epithelial
cells in skin, lungs, gastrointestinal tract, and liver. The
results of other studies suggest that adult stem/precursor
cells may cross the lineage and germ-layer boundaries and
give rise to nonhematopoietic cells. Such transdiffe-
rentiation is dependent on the niche to which they home
and also on the signals that are received from the local mi-
lieu [20,21]. It is likely that circulating progenitors may mi-
grate to damaged areas and participate in the local tissue
regeneration [22].
The results of the current study suggest that PBMNCs
could be a probable source for isolation and proliferation
of KPCs in vitro for their potential use in regenerative
medicine. It may be relevant in the event that the local
milieu is unfavorable for engraftment, mainly due to
poor blood circulation at the injured area. Under such
circumstances, transplantation of KPCs along with a bio-
mimetic scaffold as cell carrier is likely to enhance
epithelialization.
Various studies have identified the roles of p63 in epi-
dermal regeneration, which include lineage commitment,
differentiation, cell adhesion, and basement membrane
formation. This transcription factor p63 was identified on
the basis of its sequence homology with the tumor-
suppressor gene p53 [23]. However, unlike p53, p63 is
expressed in a tissue-specific manner and is expressed in
Figure 6 Immunofluorescence of cells for differentiation markers. (A) Representative image of cell stained with FITC-conjugated CK14
antibody. (B) Representative image of PE-conjugated CK5 antibody. (C) Merged images of A and B. Both CK14 and CK5 antigens are distinctly
located in the cytoplasmic region. (D) Representative image of cells stained with anti-involucrin antibody developed by PE-conjugated secondary
antibody on day 17. (E) Representative image of cells stained with anti-filaggrin antibody developed by using FITC-conjugated secondary
antibody on day 17. For negative control, fibroblasts were stained with each antibody (not shown). Scale bar is 100 μm for cytokeratin-stained
images and 50 μm for filaggrin- and involucrin-stained images.
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epidermal development, basal stem cells are induced to
express epidermal keratins CK5 and CK14 [24,25], and the
induction process is dependent on p63. Expression of p63
in cultured cells, single-layered epithelia, or embryonic
stem cells also resulted in the expression of CK5 and
CK14 [26-29]. Therefore, coexpression of p63, CK5, and
CK14 in our experiment is an excellent indication of the
epidermal lineage commitment of KPCs.
Our hypothesis was proven true as we found that circu-
lating KPCs express p63. Here, analysis of sorted CD34+
cells confirmed that they are p63-. We found that after
enrichment by Histopaque gradient centrifugation and re-
moval of plastic adherent cells, about 4% of cells are p63+;
gene amplification was clearly evident. Considering the
multipotency of progenitors in PBMNCs, predifferentiated
and lineage-committed KPCs may be better suited for
regenerative medicine to heal chronic wounds. With pro-
gress in the culture period on the niche that was designedduring this study, the cells became CK5+ and CK14+ in
flow cytometry, immunofluorescent staining, and RT-PCR.
It is interesting to note that the proliferation potential of
the cells in culture tends to be reduced by day 12, probably
because the lineage commitment progressed. When the
cells were subcultured and stained for terminal differenti-
ation markers involucrin and filaggrin, they turned positive
for both these antigens. Filaggrin is an intermediate fila-
ment (IF)-associated protein that aggregates keratin IFs
in vitro and is thought to perform a similar function during
the terminal differentiation of epidermal keratinocytes [30].
Filaggrin expression resulted in reduced keratinocyte prolif-
eration and caused an alteration in cell-cycle distribution
consistent with a post-G1-phase arrest. We also found that
PCNA expression was reduced by 15 days of KPC culture.
In keratinocytes, expression of involucrin may be regulated
by cell-substratum contact, and fibronectin at high concen-
trations can inhibit the expression [31]. In the matrix that
we composed, fibronectin content is <2 μg/cm2 of the
Figure 7 Representative images of keratinocyte progenitor cells (KPCs) on fibroblast monolayer. (A) Representative image of KPCs on
fibroblast monolayer on the day of seeding. (B) KPCs on fibroblast on day 7. (C) KPCs on fibroblast on day 17. (D) Actin-stained KPCs on
fibroblast. Magnification is the same for A and B (scale bar, 200 μm); and for C and D, the scale bar is 50 μm.
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sion on KPCs.
Previously, we reported that the fibrin matrix can be
composed with growth factors and glycosaminoglycans for
specific requirements such as growth and differentiationFigure 8 Fibrin sheet developed for transplantation of keratinocyte p
culture dish (3.3-cm diameter). (B) Fibrin sheet suspended in medium for s
(D) DAPI-stained KPCs grown on fibrin sheet for 2 days after transferring froof vascular cells and neural cells. Fibrin is abundant, well
characterized for its soft elasticity, and is useful as a
hemostatic agent and as a scaffold for tissue engineering.
Specific binding of fibrin with fibronectin, hyaluronic acid,
and many growth factors, as well as clot components, isrogenitor cells (KPCs). (A) Lyophilized fibrin sheet that was cast in
eeding KPCs. (C) Skin-like fibrin sheet after 2 days of KPC culture.
m FC matrix.
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brin and fibronectin, through which it can interact with
integrin, makes it an attractive matrix for stem cell differ-
entiation and tissue engineering. Modulation of its pro-
perties has even permitted differentiation of MSCs into
osteoblasts and mouse embryonic stem cells to neural and
astroglial lineages [33,34].
In this study, we demonstrated that a fibrin substrate
composed with specific growth factors and hyaluronic
acid permits attachment and growth of circulating kera-
tinocyte progenitors.
Survival of keratinocytes in vitro and in vivo requires a
dermal-equivalent matrix as the niche. When p63+ cells
were enriched by using a biomimetic matrix-coated dish
and transferred to the fibroblast monolayer, KPCs formed
colonies and multiplied to cover the fibroblast layer. In
skin, stem cells reside on the underlying basement mem-
brane, where they self-renew and form transit-amplifying
cells, but they do not anchor tightly to the underlying
niche. In the initial period, as no trypsinization is needed
to transfer the KPC from the selection niche to the fibro-
blast sheet or the fibrin sheet, the protocols standardized
in this study have potential applications in KPC transplant-
ation and for in vitro construction of a skin substitute for
epidermal regeneration.
Conclusion
It is a novel finding that p63 can be used as marker to
identify/enumerate KPCs in PBMNCs, which can be col-
lected by using a noninvasive procedure. In 4 days of
PBMNC culture on the designed biomimetic niche, KPC
was enriched to about 70% homogeneity. Within 12 days
of culture, the cells coexpressed p63, CK5, and CK14. The
differentiation progressed during subculture and expressed
involucrin and filaggrin and showed morphologic features
of keratinocytes. After 4 days of PBMNC culture on the
biomimetic niche, cells can be easily transferred to a fibrin/
fibroblast sheet for continued growth and differentiation.
The niche that was standardized for KPC isolation, expan-
sion, differentiation, cell survival, and the protocol for
transfer of cells to dermal equivalent may be translated into
clinical use for cell/skin-substitute transplantation.
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